ClinicalTrials.Veeva

Menu

Staining Potential and Caries Arresting Effect of Silver Diamine Fluoride⁄Potassium Iodide and Silver Diamine Fluoride

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Unknown
Phase 4

Conditions

Dental Caries in Children

Treatments

Drug: Silver Diamine Fluoride
Drug: silver diamine fluoride ⁄ potassium Iodide

Study type

Interventional

Funder types

Other

Identifiers

NCT04196829
SDF staining potential

Details and patient eligibility

About

the main objective of this study is to evaluate staining potential and Caries Arresting Effect of silver diamine fluoride⁄potassium Iodide and silver diamine fluoride in carious anterior primary teeth

Full description

Despite increased attention on caries prevention, not all children receive preventive treatments and large numbers still experience tooth decay. Primary care providers have had little option other than invasive and costly specialist treatment in the hospital under general anesthesia. In this context, there is interest in simple treatments to halt progress of carious lesions after tooth decay onset. Among these simple treatments is silver diamine fluoride (SDF) treatment. The major drawback to SDF treatment has been its black staining, which has limited its use. To counter the staining, researchers have tested SDF treatment immediately followed with application of saturated solution of potassium iodide (KI).

Enrollment

15 patients

Sex

All

Ages

3 to 5 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Children with carious primary anterior teeth.
  • Children with no spontaneous pain

Exclusion criteria

  • Tooth mobility
  • Signs of pulpal or periapical infection
  • Severe medical conditions that would not allow management in the clinic
  • Sensitivity to silver or other heavy-metal ions
  • Presence of any gingival or perioral ulceration or stomatitis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

15 participants in 2 patient groups

silver diamine fluoride ⁄ potassium Iodide
Experimental group
Description:
38% silver diamine fluoride and a saturated solution of potassium iodide
Treatment:
Drug: silver diamine fluoride ⁄ potassium Iodide
silver diamine fluoride
Active Comparator group
Description:
38% silver diamine fluoride
Treatment:
Drug: Silver Diamine Fluoride

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems